MIRM – mirum pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target lowered by analysts at JMP Securities from $72.00 to $66.00. They now have a "market outperform" rating on the stock.
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at Citigroup Inc. from $37.00 to $38.00. They now have a "buy" rating on the stock.
Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of Estimates [Yahoo! Finance]
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $40.00 price target on the stock.
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $58.00 price target on the stock.
Form 10-Q Mirum Pharmaceuticals, For: Mar 31
Form 8-K Mirum Pharmaceuticals, For: May 08
Form ARS Mirum Pharmaceuticals, For: Dec 31
Form DEFA14A Mirum Pharmaceuticals,
Form DEF 14A Mirum Pharmaceuticals, For: Apr 23
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.